BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Plompen EP, Schouten JN, Janssen HL. Role of anticoagulant therapy in liver disease. Hepatol Int. 2013;7:369-376. [PMID: 26201771 DOI: 10.1007/s12072-013-9427-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Lai HC, Chien WC, Chung CH, Lee WL, Wu TJ, Wang KY, Liu CN, Liu TJ. Atrial fibrillation, liver disease, antithrombotics and risk of cerebrovascular events: A population-based cohort study. Int J Cardiol 2016;223:829-37. [PMID: 27580216 DOI: 10.1016/j.ijcard.2016.08.297] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
2 Younossi ZM, Karrar A, Pierobon M, Birerdinc A, Stepanova M, Abdelatif D, Younoszai Z, Jeffers T, Felix S, Jeiran K, Hodge A, Zhou W, Monge F, Alaparthi L, Chandhoke V, Goodman ZD, Petricoin EF. An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease. BMC Med 2018;16:170. [PMID: 30205811 DOI: 10.1186/s12916-018-1136-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Qi X, De Stefano V, Li H, Dai J, Guo X, Fan D. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis of observational studies. Eur J Intern Med. 2015;26:23-29. [PMID: 25566699 DOI: 10.1016/j.ejim.2014.12.002] [Cited by in Crossref: 84] [Cited by in F6Publishing: 65] [Article Influence: 14.0] [Reference Citation Analysis]
4 Plompen EP, Darwish Murad S, Hansen BE, Loth DW, Schouten JN, Taimr P, Hofman A, Uitterlinden AG, Stricker BH, Janssen HL, Leebeek FW. Prothrombotic genetic risk factors are associated with an increased risk of liver fibrosis in the general population. Journal of Hepatology 2015;63:1459-65. [DOI: 10.1016/j.jhep.2015.07.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
5 王霄霄, 方秀新. 凝血功能和抗凝治疗对肝脏纤维化影响的研究进展. 世界华人消化杂志 2017; 25(10): 897-903 [DOI: 10.11569/wcjd.v25.i10.897] [Reference Citation Analysis]